Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 11, 2006, Pages 1621-1628

  Laharie, D ^a   Zerbib, F ^b   Adhoute, X ^a   Boue Lahorgue X ^a   Foucher, J ^a   Castera L ^a   Rullier, A ^c   Bertet, J ^a   Couzigou, P ^a   Amouretti, M ^a   De Ledinghen V ^a,d  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b Saint André Hospital   (France)

^c Pellegrin Hospital   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; METHOTREXATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DRUG MEGADOSE; ELASTOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEEDLE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL;

ADULT; BIOPSY; CROHN DISEASE; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; ELASTICITY; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33646558276     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02929.x     Document Type: Article

References (37)

1. Weinblatt ME Coblyn JS Fox DA et al. Efficacy of low-dose methotrexate in rheumatoid arthritis N Engl J Med 1985 312 818 22
2. Willkens RF Williams HJ Ward JR et al. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis Arthritis Rheum 1984 27 376 81
3. Feagan BG Rochon J Fedorak RN et al. for the North American Crohn's Study Group Investigators. Methotrexate in the treatment of Crohn's disease N Engl J Med 1995 332 292 7
4. Noman M Vermeire S Van Assche G et al. The effectiveness of immunosuppression to suppress the formation of antibodies to infliximab in Crohn's disease Gastroenterology 2004 126 A54 abstract
5. Feagan BG Fedorak RN Irvine EJ et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease N Engl J Med 2000 342 1627 32
6. Lemann M Zenjari T Bouhnik Y et al. Methotrexate in Crohn's disease: long-term efficacy and toxicity Am J Gastroenterol 2000 95 1730 4
7. Bridges SL Alarcon JM Koopman WJ Methotrexate-induced liver abnormalities in rheumatoid arthritis J Rheumatology 1989 16 1180 3
8. Lanse SB Arnold GL Gowans JD Kaplan MM Low incidence hepatotoxicity associated with long-term low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio Dig Dis Sci 1985 30 104 9
9. Te HS Schiano TD Fan Kuan S Hanauer SB Conjeevaram HS Baker AL Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease Am J Gastroenterol 2000 95 3150 6
10. Rau R Karger T Herborn G Frenzel H Liver biopsy findings in patients with rheumatoid arthritis undergoing long-term treatment with methotrexate J Rheumatol 1989 16 489 93
11. Kremer JM Alarcon GS Lightfoot RWJ et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology Arthritis Rheum 1994 37 316 28
12. Cadranel JF Rufat P Degos F Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF) Hepatology 2000 32 477 81
13. Bravo AA Sheth SG Chopra S Liver biopsy N Engl J Med 2001 344 495 500
14. Chande N Ponich T Gregor J A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn's disease Can J Gastroenterol 2005 19 553 8
15. Bedossa P Dargère D Paradis V Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 2003 38 1449 57
16. Colloredo G Guido M Sonzogni A Leandro G Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease J Hepatol 2003 39 239 44
17. Maharaj B Maharaj RJ Leary WP et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1986 1 523 5
18. Wai CT Greenson JK Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 2003 38 518 26
19. Imbert-Bismut F Ratziu V Pieroni L Charlotte F Benhamou Y Poynard T MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 2001 357 1069 75
20. ®) in HIV-HCV co-infected patients J Acquir Immune Defic Syndr 2006 41 175 9
21. Castera L Vergniol J Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 2005 128 343 50
22. ®): a prospective study Gut 2006 55 403 8
23. Ziol M Handra-Luca A Kettaneh A et al. Non-invasive assessment of liver fibrosis by stiffness measurement: a prospective multicenter study in patients with chronic hepatitis C Hepatology 2005 41 48 54
24. Sandrin L Fourquet B Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 2003 29 1705 13
25. Said S Jeffes EW Weinstein GD Methotrexate Clin Dermatol 1997 15 781 97
26. Roenigk HH Auerbach R Maibach HI Weinstein GD Methotrexate in psoriasis: revised guidelines J Am Acad Derm 1988 19 145 57
27. Fraser AG Morton D McGovern D Travis S Jewell DP The efficacy of methotrexate for maintaining remission in inflammatory bowel disease Aliment Pharmacol Ther 2002 16 693 7
28. Chong RY Hanauer SB Cohen RD Efficacy of parenteral methotrexate in refractory Crohn's disease Aliment Pharmacol Ther 2001 15 35 44
29. Morgan SL Baggott JE Vaughn WH et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial Ann Intern Med 1994 121 833 41
30. Van Ede AE Laan RF Rood MJ et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis Arthritis Rheum 2001 44 1515 24
31. Whithing-O'Keefe QE Fye KH Sack KD Methotrexate and histologic hepatic abnormalities: a meta-analysis Am J Med 1991 90 711 6
32. Kremer JM Lee RG Tolman KG Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy Arthritis Rheum 1989 32 121 7
33. Dordal E Glagov S Kirsner JB Hepatic lesions in chronic inflammatory bowel disease. I. Clinical correlations with liver biopsy diagnoses in 103 patients Gastroenterology 1967 52 239 53
34. Siddique I El-Naga HA Madda JP Memon A Hasan F Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection Scand J Gastroenterol 2003 38 427 32
35. The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 1994 20 15 20
36. Regev A Berho M Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 2002 97 2614 8
37. Afdhal NH Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests Hepatology 2003 37 972 4